May 10, 2016
2:1
For every share held, investors received 2. The price per share adjusted from $28.88 to $14.44.
The split itself did not change the total investment value.
Hunan Er-Kang Pharmaceutical Co., Ltd. Class A (SZSE:300267) operates in the Pharmaceuticals: major industry.
Hunan Er-Kang Pharmaceutical Co., Ltd. Class A company overviewHunan Er-Kang Pharmaceutical Co., Ltd. Class A's most recent stock split was on May 10, 2016. It was a 2-for-1 forward split, so shareholders received 2 shares for every share they held.
Hunan Er-Kang Pharmaceutical Co., Ltd. Class A (SZSE:300267) has split its stock 4 times: a 13-for-10 split on April 17, 2012, a 57-for-25 split on March 5, 2014, a 2-for-1 split on April 8, 2015, and a 2-for-1 split on May 10, 2016.
Hunan Er-Kang Pharmaceutical Co., Ltd. Class A has split its stock 4 times. This history records 4 forward splits between April 17, 2012 and May 10, 2016.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Hunan Er-Kang Pharmaceutical Co., Ltd. Class A's 2-for-1 split on May 10, 2016, every share became 2 shares.
Hunan Er-Kang Pharmaceutical Co., Ltd. Class A has not announced a new split in our records. Its most recent split was on May 10, 2016, 10 years ago. Companies announce splits in advance, and any new SZSE:300267 split will appear on this page.
Already premium?